Intense pulsed light

Last updated

Intense pulsed light (IPL) is a technology used by cosmetic and medical practitioners to perform various skin treatments for aesthetic and therapeutic purposes, including hair removal, photorejuvenation (e.g. the treatment of skin pigmentation, sun damage, and thread veins) as well as to alleviate dermatologic diseases such as acne. [1] [2] [3] [4] [ citation needed ] IPL is increasingly used in optometry and ophthalmology as well, to treat evaporative dry eye disease due to meibomian gland dysfunction. [5] [6] [7] [8]

Contents

The technology uses a high-powered, hand-held, computer-controlled flashgun to deliver an intense, visible, broad-spectrum pulse of light, generally in the visible spectral range of 400 to 1200 nm. Various cutoff filters are commonly used to selectively filter out shorter wavelengths, especially potentially damaging ultraviolet light. The resulting light has a spectral range that targets specific structures and chromophores (e.g. melanin in hair, or oxyhemoglobin in blood vessels) that are heated to destruction and reabsorbed by the body. IPL shares some similarities with laser treatments, in that they both use light to heat and destroy their targets. But unlike lasers that use a single wavelength (color) of light which typically matches only one chromophore and hence only treats one condition, IPL uses a broad spectrum that when used with interchangeable filters, allowing it to be used against several conditions. This can be achieved when the IPL technician selects the appropriate filter that matches a specific chromophore. [9]

Description

Intense pulsed light is the use of intense pulses of non-coherent light over a range of wavelengths from 500 nm to 1200 nm. [10] Xenon flashlamps produce high output bursts of broad spectrum. Cooling is used to protect the skin in contact with the device. [11]

Regulations governing IPL vary by jurisdiction. [12] [ better source needed ] A distinction is sometimes made[ by whom? ] between beauty-grade and medical-grade machines, mainly to get around regulations.

The first FDA approval of IPL was for telangiectasias in 1995. Use quickly spread to a variety of medical and cosmetic settings. [13] Treatment is generally safe and effective, but complications can occur, such as hyperpigmentation. [14] [13] The polychromatic light can reach multiple chromophores in human skin: mainly hemoglobin, water, and melanin. [15] This results in selective photothermolysis of blood vessels, pigmented cells, or hair follicles.[ citation needed ]

Hair removal

IPL can reduce hair growth, most effectively in darker, coarser hair. [16] IPL is distinct from laser hair removal which uses coherent monochromatic laser light. [17]

Protocol

Broad-spectrum light is applied to the surface of the skin, targeting melanin. This light travels through the skin until it strikes the hair shafts or hair follicle. [18] The follicle is usually where the highest concentration of melanin is located. [13] As the light is absorbed, the bulb and most of the hair shaft are heated, destroying the hair-producing papilla. [18] It is also claimed that heat conversion occurs directly in the darker capillaries that bring blood to the follicle. [19]

At any one time, not all hair follicles are 'active', and only active hair follicles can be affected by the treatment. [17] 'Inactive' hair follicles can be treated as they become 'active' over time.[ citation needed ] For IPL treatments, an average of 8–10 treatments, 4–6 weeks apart, are required to remove most visible hair. [19]

There is no common treatment protocol, as it depends on the equipment used and patient skin type. The area to be treated should be clean shaven and free of sunburn. [20]

Although IPL treatments will permanently reduce the total number of body hairs, they will not result in a permanent removal of all hair. [21]

Certain skin conditions, health irregularities, and medications can impact whether it is safe for a person to receive a light-based hair removal treatment.[ citation needed ] Photo-sensitizing medications, or damage to the skin are contraindications to treatment. According to Remington, manufacturer of an IPL device, all IPL and laser devices should only be used on light to medium skin tones, and work best on darker hair. [22]

Efficacy

In August 1997, IPL was reported to have permanently removed terminal hair in two patients who underwent multiple treatments to their beards. [13] In October of that year, the first IPL system developed for hair removal and resulted in 60% hair reduction after 12 weeks. [23]

It is important to note that these studies utilized a variety of IPL devices on patients with various hair types, skin types, and targeted skin areas. Thus the results are not directly comparable.

According to the FDA, permanent hair removal means the "long-term, stable reduction in the number of hairs regrowing after a treatment regime." In other words, the number of hairs regrowing must be consistently greater than the duration of the complete growth cycle of hair follicles, which varies from four to twelve months by body location. [24] IPL has been found to be much less effective than laser hair removal; however, many patients experience satisfaction with significant hair reduction. [21]

A 2006 article in the journal Lasers in Medical Science compared IPL and both alexandrite and diode lasers. The review found no statistical difference in effectiveness, but a higher incidence of side effects with diode laser treatment. Hair reduction after six months was reported as 68.75% for alexandrite lasers, 71.71% for diode lasers, and 66.96% for IPL. Side effects were reported as 9.5% for alexandrite lasers, 28.9% for diode lasers, and 15.3% for IPL. All side effects were found to be temporary and even pigmentation changes returned to normal within six months. [25]

A 2009 study evaluated the rate of hair removal after a second generation IPL source. Results found that patients had 75% hair reduction after four months, and up to 80% after eight months. [26] [27]

Medical use

IPL was first developed for vascular conditions. It is at least as effective as pulsed dye lasers and can penetrate deeper with reduced risk of purpura and hyperpigmentation. IPL can also be used for the treatment of dry eye conditions such as meibomian gland dysfunction. [28] [29] IPL can treat pigmented lesions with rapid recovery. Dyschromia can be cleared after repeated sessions. Photoaging treatment has been explored. A series of IPL can be used for facial rejuvenation, improving skin laxity and collagen production. IPL combined with facial injections can be used for dynamic rhytids. Home IPL devices have been developed.

IPL is employed in the treatment of a range of dermatological conditions including photodamage induced dyspigmentation and vascular changes, poikiloderma of Civatte, rosacea, acne vulgaris, sebaceous gland hyperplasia, broken capillaries, telangiectases, vascular lesions (small blood vessels), pigmented lesions (freckles, liver spots, birth marks ), melasma, actinic keratosis, photorejuvenation, basal cell carcinoma, and Bowen's disease (squamous cell carcinoma). [30]

See also

Further reading

Related Research Articles

<span class="mw-page-title-main">Hair</span> Protein filament that grows from follicles found in the dermis, or skin

Hair is a protein filament that grows from follicles found in the dermis. Hair is one of the defining characteristics of mammals. The human body, apart from areas of glabrous skin, is covered in follicles which produce thick terminal and fine vellus hair. Most common interest in hair is focused on hair growth, hair types, and hair care, but hair is also an important biomaterial primarily composed of protein, notably alpha-keratin.

<span class="mw-page-title-main">Acne</span> Skin condition characterized by pimples

Acne, also known as acne vulgaris, is a long-term skin condition that occurs when dead skin cells and oil from the skin clog hair follicles. Typical features of the condition include blackheads or whiteheads, pimples, oily skin, and possible scarring. It primarily affects skin with a relatively high number of oil glands, including the face, upper part of the chest, and back. The resulting appearance can lead to lack of confidence, anxiety, reduced self-esteem, and, in extreme cases, depression or thoughts of suicide.

<span class="mw-page-title-main">Hair removal</span> Temporary removal of body hair

Hair removal, also known as epilation or depilation, is the deliberate removal of body hair or head hair.

<span class="mw-page-title-main">Sebaceous gland</span> Gland to lubricate the hair and skin

A sebaceous gland, or oil gland, is a microscopic exocrine gland in the skin that opens into a hair follicle to secrete an oily or waxy matter, called sebum, which lubricates the hair and skin of mammals. In humans, sebaceous glands occur in the greatest number on the face and scalp, but also on all parts of the skin except the palms of the hands and soles of the feet. In the eyelids, meibomian glands, also called tarsal glands, are a type of sebaceous gland that secrete a special type of sebum into tears. Surrounding the female nipple, areolar glands are specialized sebaceous glands for lubricating the nipple. Fordyce spots are benign, visible, sebaceous glands found usually on the lips, gums and inner cheeks, and genitals.

<span class="mw-page-title-main">Nd:YAG laser</span> Crystal used as a lasing medium for solid-state lasers

Nd:YAG (neodymium-doped yttrium aluminum garnet; Nd:Y3Al5O12) is a crystal that is used as a lasing medium for solid-state lasers. The dopant, triply ionized neodymium, Nd(III), typically replaces a small fraction (1%) of the yttrium ions in the host crystal structure of the yttrium aluminum garnet (YAG), since the two ions are of similar size. It is the neodymium ion which provides the lasing activity in the crystal, in the same fashion as red chromium ion in ruby lasers.

<span class="mw-page-title-main">Hidradenitis suppurativa</span> Human disease

Hidradenitis suppurativa (HS), sometimes known as acne inversa or Verneuil's disease, is a long-term dermatological condition characterized by the occurrence of inflamed and swollen lumps. These are typically painful and break open, releasing fluid or pus. The areas most commonly affected are the underarms, under the breasts, and the groin. Scar tissue remains after healing. HS may significantly limit many everyday activities, for instance, walking, hugging, moving, and sitting down. Sitting disability may occur in patients with lesions in sacral, gluteal, perineal, femoral, groin or genital regions; and prolonged periods of sitting down itself can also worsen the condition of the skin of these patients.

<span class="mw-page-title-main">Laser hair removal</span> Process of hair removal by exposure to laser pulses

Laser hair removal is the process of hair removal by means of exposure to pulses of laser light that destroy the hair follicle. It had been performed experimentally for about twenty years before becoming commercially available in 1995 and 1996. One of the first published articles describing laser hair removal was authored by the group at Massachusetts General Hospital in 1998. Laser hair removal is widely practiced in clinics, and even in homes using devices designed and priced for consumer self-treatment. Many reviews of laser hair removal methods, safety, and efficacy have been published in the dermatology literature.

<span class="mw-page-title-main">Hyperpigmentation</span> Darkening of an area of skin or nails caused by increased melanin

Hyperpigmentation is the darkening of an area of skin or nails caused by increased melanin.

<span class="mw-page-title-main">Hypopigmentation</span> Area of skin becoming lighter than the baseline skin color

Hypopigmentation is characterized specifically as an area of skin becoming lighter than the baseline skin color, but not completely devoid of pigment. This is not to be confused with depigmentation, which is characterized as the absence of all pigment. It is caused by melanocyte or melanin depletion, or a decrease in the amino acid tyrosine, which is used by melanocytes to make melanin. Some common genetic causes include mutations in the tyrosinase gene or OCA2 gene. As melanin pigments tend to be in the skin, eye, and hair, these are the commonly affected areas in those with hypopigmentation.

<span class="mw-page-title-main">Keratosis pilaris</span> Skin condition characterized by small bumps caused by overproduction of keratin

Keratosis pilaris is a common, autosomal-dominant, genetic condition of the skin's hair follicles characterized by the appearance of possibly itchy, small, gooseflesh-like bumps, with varying degrees of reddening or inflammation. It most often appears on the outer sides of the upper arms, thighs, face, back, and buttocks; KP can also occur on the hands, and tops of legs, sides, or any body part except glabrous (hairless) skin. Often the lesions can appear on the face, which may be mistaken for acne or folliculitis.

<span class="mw-page-title-main">Melasma</span> Medical condition

Melasma is a tan or dark skin discoloration. Melasma is thought to be caused by sun exposure, genetic predisposition, hormone changes, and skin irritation. Although it can affect anyone, it is particularly common in women, especially pregnant women and those who are taking oral or patch contraceptives or hormone replacement therapy medications.

<span class="mw-page-title-main">Pseudofolliculitis barbae</span> Medical condition

Pseudofolliculitis barbae (PFB) is a type of irritant folliculitis that commonly affects men who have curly or coarse facial hair. It occurs when hair curls back into the skin after shaving, causing inflammation, redness, and bumps. This can lead to ingrown hairs, scarring, and skin discoloration. PFB can be treated with various methods, including changing shaving habits, using topical creams or ointments, and undergoing laser hair removal. Prevention measures include proper shaving techniques, using sharp razors, and avoiding too close a shave.

<span class="mw-page-title-main">Meibomian gland</span> Sebaceous glands along the rims of the eyelid

Meibomian glands are sebaceous glands along the rims of the eyelid inside the tarsal plate. They produce meibum, an oily substance that prevents evaporation of the eye's tear film. Meibum prevents tears from spilling onto the cheek, traps them between the oiled edge and the eyeball, and makes the closed lids airtight. There are about 25 such glands on the upper eyelid, and 20 on the lower eyelid.

<span class="mw-page-title-main">Comedo</span> Medical condition

A comedo is a clogged hair follicle (pore) in the skin. Keratin combines with oil to block the follicle. A comedo can be open (blackhead) or closed by skin (whitehead) and occur with or without acne. The word "comedo" comes from the Latin comedere, meaning "to eat up", and was historically used to describe parasitic worms; in modern medical terminology, it is used to suggest the worm-like appearance of the expressed material.

<span class="mw-page-title-main">Congenital melanocytic nevus</span> Congenital mole caused by genetic mutations

The congenital melanocytic nevus is a type of melanocytic nevus found in infants at birth. This type of birthmark occurs in an estimated 1% of infants worldwide; it is located in the area of the head and neck 15% of the time.

<span class="mw-page-title-main">Tattoo removal</span> Dermatologic procedure to remove tattoo pigments

Tattoo removal is the process of removing an unwanted tattoo. The process of tattooing generally creates permanent markings in the skin, but people have attempted many methods to try to hide or destroy tattoos.

Photorejuvenation is a skin treatment that uses lasers, intense pulsed light, or photodynamic therapy to treat skin conditions and remove effects of photoaging such as wrinkles, spots, and textures. The process induces controlled wounds to the skin. This prompts the skin to heal itself, by creating new cells. This process—to a certain extent—removes the signs of photoaging. The technique was invented by Thomas L Roberts, III using CO2 lasers in the 1990s. Observed complications have included scarring, hyperpigmentation, acne, and herpes.

Madarosis is a condition that results in the loss of eyelashes, and sometimes eyebrows. The term "madarosis" is derived from the ancient Greek "madaros", meaning "bald". It originally was a disease of only losing eyelashes but it currently is the loss of both eyelashes and eyebrows. Eyebrows and eyelashes are both important in the prevention of bacteria and other foreign objects from entering the eye. A majority of patients with madarosis have leprosy, and it was reported that 76% of patients with varying types of leprosy had madarosis.

Oral pigmentation is asymptomatic and does not usually cause any alteration to the texture or thickness of the affected area. The colour can be uniform or speckled and can appear solitary or as multiple lesions. Depending on the site, depth, and quantity of pigment, the appearance can vary considerably.

<span class="mw-page-title-main">Prepubertal hypertrichosis</span> Medical condition

Prepubertal hypertrichosis, also known as childhood hypertrichosis, is a cutaneous condition characterized by increased hair growth, found in otherwise healthy infants and children. Prepubertal hypertrichosis is a cosmetic condition and does not affect any other health aspect. Individuals with this condition may suffer with low self esteem and mental health issues due to societal perceptions of what a "normal" appearance should be. The mechanism of prepubertal hypertrichosis is unclear, but causes may include genetics, systemic illnesses, or medications.

References

  1. Kumaresan, M; Srinivas, C R (2010-01-01). "Efficacy of IPL in treatment of acne vulgaris : Comparison of single- and burst-pulse mode in IPL". Indian Journal of Dermatology. 55 (4): 370–372. doi: 10.4103/0019-5154.74550 . ISSN   0019-5154. PMC   3051300 . PMID   21430893.
  2. Wat, Heidi; Wu, Douglas C.; Rao, Jaggi; Goldman, Mitchel P. (2014-04-01). "Application of intense pulsed light in the treatment of dermatologic disease: a systematic review". Dermatologic Surgery. 40 (4): 359–377. doi:10.1111/dsu.12424. ISSN   1524-4725. PMID   24495252. S2CID   205081994.
  3. Piccolo, D.; Di Marcantonio, D.; Crisman, G.; Cannarozzo, G.; Sannino, M.; Chiricozzi, A.; Chimenti, S. (2014-01-01). "Unconventional use of intense pulsed light". BioMed Research International. 2014: 618206. doi: 10.1155/2014/618206 . ISSN   2314-6141. PMC   4167959 . PMID   25276803.
  4. Belenky, Inna; Tagger, Cruzy; Bingham, Andrea (2015-11-01). "Intense Pulsed Light Pulse Configuration Manipulation Can Resolve the Classic Conflict Between Safety and Efficacy". Journal of Drugs in Dermatology. 14 (11): 1255–1260. ISSN   1545-9616. PMID   26580874.
  5. Toyos, Rolando; McGill, William; Briscoe, Dustin (2015-01-01). "Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study". Photomedicine and Laser Surgery. 33 (1): 41–46. doi:10.1089/pho.2014.3819. ISSN   1557-8550. PMC   4298157 . PMID   25594770.
  6. Vegunta, Sravanthi; Patel, Dharmendra; Shen, Joanne F. (2016-03-01). "Combination Therapy of Intense Pulsed Light Therapy and Meibomian Gland Expression (IPL/MGX) Can Improve Dry Eye Symptoms and Meibomian Gland Function in Patients With Refractory Dry Eye: A Retrospective Analysis". Cornea. 35 (3): 318–322. doi:10.1097/ICO.0000000000000735. ISSN   1536-4798. PMID   26785301. S2CID   24896902.
  7. Vora, Gargi K.; Gupta, Preeya K. (2015-07-01). "Intense pulsed light therapy for the treatment of evaporative dry eye disease". Current Opinion in Ophthalmology. 26 (4): 314–318. doi:10.1097/ICU.0000000000000166. ISSN   1531-7021. PMID   26058031. S2CID   39053597.
  8. Craig, Jennifer P.; Chen, Yen-Heng; Turnbull, Philip R. K. (2015-03-01). "Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction". Investigative Ophthalmology & Visual Science. 56 (3): 1965–1970. doi:10.1167/iovs.14-15764. ISSN   1552-5783. PMID   25678687.
  9. Gold, Michael H. (September–October 2007). "Lasers and light sources for the removal of unwanted hair". Clinics in Dermatology. 25 (5): 443–453. doi:10.1016/j.clindermatol.2007.05.017. PMID   17870522.
  10. "Intense Pulsed Light Systems" (PDF). HMP Communications. Archived from the original (PDF) on 27 November 2010. Retrieved 2 August 2012.
  11. Lahiri, Koushik (2016-07-30). Textbook of Lasers in Dermatology. JP Medical Ltd. ISBN   978-93-85999-62-8.
  12. "Laser Information". Florida Department of Health. Archived from the original on November 4, 2012. Retrieved 2 August 2012.
  13. 1 2 3 4 Goldberg, David J. (June 2012). "Current Trends in Intense Pulsed Light". The Journal of Clinical and Aesthetic Dermatology. 5 (6): 45–53. ISSN   1941-2789. PMC   3390232 . PMID   22768357.
  14. "Current Trends in Intense Pulsed Light". Clin Aesthet Dermatol. Jun 2012.
  15. Tseng, Sheng-Hao; Bargo, Paulo; Durkin, Anthony; Kollias, Nikiforos (2009-08-17). "Chromophore concentrations, absorption and scattering properties of human skin in-vivo". Optics Express. 17 (17): 14599–14617. Bibcode:2009OExpr..1714599T. doi:10.1364/oe.17.014599. ISSN   1094-4087. PMC   2754563 . PMID   19687939.
  16. Campbell, Leigh (2016-01-07). "The Difference Between Laser And IPL For Permanent Hair Removal". Huffington Post. Retrieved 2020-03-17.
  17. 1 2 Young, Katy (2018-04-11). "Does IPL hair removal really work?". The Telegraph. ISSN   0307-1235 . Retrieved 2020-03-17.
  18. 1 2 Husain, Zain; Alster, Tina S (2016-02-04). "The role of lasers and intense pulsed light technology in dermatology". Clinical, Cosmetic and Investigational Dermatology. 9: 29–40. doi: 10.2147/CCID.S69106 . ISSN   1178-7015. PMC   4745852 . PMID   26893574.
  19. 1 2 Lahiri, Koushik (2016-07-30). Textbook of Lasers in Dermatology. JP Medical Ltd. p. 55. ISBN   978-93-85999-62-8.
  20. Lahiri, Koushik (2016-07-30). Textbook of Lasers in Dermatology. JP Medical Ltd. ISBN   978-93-85999-62-8.
  21. 1 2 Klein, A.; Steinert, S.; Baeumler, W.; Landthaler, M.; Babilas, P. (1 December 2012). "Photoepilation with a diode laser vs. intense pulsed light (IPL): a randomized, intra-patient left-to-right trial". British Journal of Dermatology. 168 (6): 1287–93. doi:10.1111/bjd.12182. PMID   23278132. S2CID   8889666.
  22. "Trends & Tips - Remington". uk.remington-europe.com.
  23. Gold, Michael H.; Bell, Michael W.; Foster, Teresa D.; Street, Sherri (October 1997). "Long-term epilation using the EpiLight broad band, intense pulsed light Hair Removal System". Dermatologic Surgery. 23 (10): 909–913. doi:10.1111/j.1524-4725.1997.tb00746.x. PMID   9357500. S2CID   25398697.
  24. "Laser Facts". FDA. Archived from the original on September 12, 2014. Retrieved 23 September 2014.
  25. Toosi, Parviz; Sadighha, Afshin; Sharifian, Ali; Razavi, Gita Meshkat (April 2006). "A comparison study of the efficacy and side effects of different light sources in hair removal". Lasers in Medical Science. 21 (1): 1–4. doi:10.1007/s10103-006-0373-2. PMID   16583183. S2CID   10093379.
  26. Smith, S.R.; Y. Tse; S.K. Adsit; et al. (1998). "Long-term results of hair photo-epilation". Lasers Surg Med: 43.
  27. Troilus, A.; Troilus C (September 1999). "Hair removal with a second generation broad spectrum intense pulsed light source—a long term follow-up". J Cutan Laser Ther. 1 (3): 173–178. doi:10.1080/14628839950516832. PMID   11360414.
  28. Annie Stuart (July 2012). "Managing Blepharitis:Tried-and-True and New Approaches" (PDF). EyeNet. Archived from the original (PDF) on March 5, 2015. Retrieved February 22, 2015.
  29. Aldave, Anthony J.; Afshari, Natalie; Colby, Kathryn (10 November 2012). "Pushing Surgical Boundaries, Professional Development, and Popular Opinion" (PDF). The American Academy of Ophthalmology. Archived from the original (PDF) on January 23, 2013. Retrieved February 22, 2015.
  30. Wat, Heidi; Wu, Douglas C.; Rao, Jaggi; Goldman, Mitchel P. (Apr 2014). "Application of intense pulsed light in the treatment of dermatologic disease: a systematic review". Dermatol. Surg. 40 (4): 359–77. doi:10.1111/dsu.12424. PMID   24495252. S2CID   205081994.